O. Farges, D. Fuks, E. Boleslawski, L. Treut, Y. Castaing et al., Influence of surgical 1 margins on outcome in patients with intrahepatic cholangiocarcinoma: a multicenter study by the

, AFC-IHCC-2009 study group, Ann Surg, vol.254, pp.824-830, 2011.

G. P. Wright, S. Perkins, H. Jones, A. H. Zureikat, J. W. Marsh et al.,

, Does Not Improve Survival in Multifocal Intrahepatic Cholangiocarcinoma: A Comparison of Surgical 5 Resection with Intra-Arterial Therapies, Ann Surg Oncol, vol.25, pp.83-90, 2018.

J. Edeline, C. Coulouarn, L. Crouzet, M. Pracht, N. Lepareur et al.,

. Oxaliplatin, Not Sorafenib or Paclitaxel, Have a Synergistic Effect with Yttrium-90 in Reducing 8

, Hepatocellular Carcinoma and Cholangiocarcinoma Cell Line Viability, J Vasc Interv Radiol JVIR, vol.9, pp.1874-1878, 2015.

E. Garin, Y. Rolland, S. Laffont, and E. J. , Clinical impact of (99m)Tc-MAA SPECT/CT-based dosimetry 11 in the radioembolization of liver malignancies with (90)Y-loaded microspheres, Eur J Nucl Med Mol 12 Imaging, vol.43, pp.559-75, 2016.

J. Edeline, Selective Internal Radiation Therapy (SIRT) with Yttrium-90-glass-microspheres 14 plus chemotherapy in first-line treatment of advanced cholangiocarcinoma (MISPHEC study)

R. Kloeckner, C. Ruckes, K. Kronfeld, M. A. Wörns, A. Weinmann et al., Selective internal 17 radiotherapy (SIRT) versus transarterial chemoembolization (TACE) for the treatment of intrahepatic 18 cholangiocellular carcinoma (CCC): study protocol for a randomized controlled trial, Trials, vol.19, p.311, 2014.